Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Any news due here?
Another big buy or sell wtf is going on
Their approach is quite a bit different in terms of the science. Maybe they used the same web page design tech?
But they seem like a good set up and I would rather invest in them than the likes of Seres.
Sangi just had a quick look at Enterome website. The chart they show with the progress of each of their drugs at the various phase 1/2/3 stage development is so similar to ours presentation wise. Did they copy us or did we copy them?
There's another company in the space. Enterome. I would really like to invest but they are unlisted.
Their investors don't have an SP to be concerned about. I wonder how they manage?
Sangi I am well retired and look forward at 7am each morning to see if we have an RNS. And yes I do enjoy looking at the share each day together with with gardening, walking. shopping and taking out my grandchildren. Its a good life and I am very fortunate.
Do you find it helpful watching the SP on a daily basis?
Bigbench I suppose people have seen this go up then down a number of times and then start thinking what if the trial results are not as good as we are expecting. Doubt begins to creep in. I am keeping the faith for good or bad but it does annoy me when we go over £1 and then retrace. In my case I haven't got the money to buy more.
Why would any holders sell? (unless desperate for money elsewhere)......plenty upside from this point just sit back & relax.
Funny cos I am inclined to buy on the sells
Someone's still determined to sell as soon as there is any hint of buying.
Mm’s working hsrd to get price as low as poss to allow favoured traders to buy at the moment.
It’s all in their hands when there is the autobot at full pelt and just the odd private buy.
I had no trouble buying today up to lots of £5k
This as usual could go either way atm as it’s just a puppet share divorced from company value and prospects.
Been hard to buy in quantity today. Always NT to buy .Some decent buys earlier on in the day also.Hopefully the tide may be turning.Director’s bought loads at the last fund raise at £1.10 !!!
Plus 1 million share purchase . £844k
Now both could actually be sells.
Impossible to know as they are accumulated tradrs reported after the bell.
Unusual activity for 4D though.
So hard when you can’t be sure if buys or sells thoigh. Can only speculate . And speculate on who? World Quant??
All mysterious ( to me anyway).
Reported after the bell, not small change.